CDK2 and lung adenocarcinoma: Forced over-expression of miR-186 in lung adenocarcinoma cells inhibits proliferation and invasion by targeting and inhibiting the cyclin D1, cyclin-dependent kinase 2 (CDK2), and CDK6 genes [26] and pituitary tumor transforming gene [27].